Bausch Health Companies Inc. Contracts & Agreements

248 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Supplemental Letter Agreement between Bausch Health Companies Inc. and Icahn Group Regarding Board Representation and Voting Rights
Bausch Health Companies Inc.
Pharmaceuticals
2025
Director Nomination and Resignation Letter Agreement between Bausch Health Companies Inc. and John Paulson
Bausch Health Companies Inc.
Pharmaceuticals
2025
Director Letter Agreement between Bausch Health Companies Inc. and Sarah B. Kavanagh (May 2025)
Bausch Health Companies Inc.
Pharmaceuticals
2025
Amended and Restated Employment Agreement between Bausch Health Companies Inc. and Aimee Lenar
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2025
Employment Agreement between Bausch Health Companies Inc. and Jean-Jacques Charhon
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2024
Bausch Health Letter Agreement with John Barresi Regarding Restricted Stock Unit Grant, Stipend, and Enhanced Severance Benefits
Compensation Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2024
Amended and Restated Employee Matters Agreement between Bausch Health Companies Inc. and Bausch + Lomb Corporation (July 31, 2024)
Separation Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2024
Second Amendment to Credit and Security Agreement among Bausch Receivables Funding LP, Bausch Health US, LLC, GLAS USA LLC, and Lenders
Credit Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2024
Interim Chief Financial Officer Compensation and Retention Agreement between Bausch Health Companies Inc. and John S. Barresi
Compensation Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2024
Credit and Security Agreement among Bausch Receivables Funding LP, Bausch Health US, LLC, and Lenders (June 30, 2023)
Credit Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2023
Stock and Asset Purchase Agreement among Novartis Pharma AG, Novartis Finance Corporation, and Bausch + Lomb Ireland Limited
Purchase Agreements
Bausch Health Companies Inc.
Pharmaceuticals
DE
2023
Bausch Health Companies Inc. Performance Share Unit Grant Agreement (2014 Omnibus Incentive Plan)
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
WA
2023
Sixteenth Supplemental Indenture to 9.250% Senior Notes Due 2026 between Bausch Health Americas, Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2022
Fifteenth Supplemental Indenture to 7.250% Senior Notes Due 2029 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2022
Fourteenth Supplemental Indenture to 7.000% Senior Notes Due 2028 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2022
Fourteenth Supplemental Indenture to 5.000% Senior Notes Due 2028 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2022
Sixteenth Supplemental Indenture to 8.500% Senior Notes Due 2027 between Bausch Health Americas, Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2022
Indenture for $1,774,067,000 11.00% Senior Secured Notes Due 2028 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
DE
2022
Indenture for Bausch Health Companies Inc. $351,533,000 14.000% Second Lien Secured Notes Due 2030
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
DE
2022
Indenture for $998,937,000 9.000% Senior Secured Notes Due 2028 between 1375209 B.C. Ltd. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2022
Employment Agreement between Bausch Health Companies Inc. and Tom Vadaketh (CFO)
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2022
Employment Agreement between Bausch Health Companies Inc. and Seana Carson (General Counsel)
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2022
Employment Agreement between Bausch Health Companies Inc. and Robert Spurr
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
WA
2022
Amendment to Employment Agreement between Bausch Health Companies Inc. and Robert Spurr
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2022
Employment Agreement between Bausch Health Companies Inc. and Robert Spurr (President, Salix)
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
WA
2022
Bausch Health Companies Inc. Restricted Share Unit Award Agreement (2014 Omnibus Incentive Plan)
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
WA
2022
Bausch Health Companies Inc. Nonstatutory Stock Option Grant Agreement (2014 Omnibus Incentive Plan)
Warrant Agreements
Bausch Health Companies Inc.
Pharmaceuticals
WA
2022
Amended and Restated Employment Agreement between Bausch Health Companies Inc. and Thomas J. Appio
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2022
Bausch Health Companies Inc. Performance Restricted Share Unit Grant Agreement (2014 Omnibus Incentive Plan)
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
WA
2021
Amendment to Employment Agreement between Bausch Health Companies Inc. and Paul Herendeen
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2021
Employment Agreement between Bausch Health Companies Inc. and Sam Eldessouky (Executive Vice President & CFO)
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
WA
2021
Indenture for $1,600,000,000 4.875% Senior Secured Notes Due 2028 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
DE
2021
Bausch Health Companies Inc. Performance Share Unit Grant Agreement (2014 Omnibus Incentive Plan)
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
WA
2021
Bausch Health Companies Inc. 2014 Omnibus Incentive Plan (Amended and Restated as of April 28, 2020)
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2021
Bausch Health Spinoff Bonus and Enhanced Severance Letter Agreement for Key Employee
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2021
Director Appointment and Nomination Agreement between Bausch Health Companies Inc. and the Icahn Group (February 2021)
Voting Agreements
Bausch Health Companies Inc.
Pharmaceuticals
DE
2021
Indenture for $1,000,000,000 5.000% Senior Notes Due 2029 and $1,000,000,000 5.250% Senior Notes Due 2031 by Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2020
Indenture for $1,500,000,000 6.250% Senior Notes Due 2029 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2020
Description of Registered Common Shares of Bausch Health Companies Inc.
Equity Distribution Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2020
Bausch Health Companies Inc. 2014 Omnibus Incentive Plan (Amended and Restated as of April 30, 2018)
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2020
Stipulation of Settlement in Valeant Pharmaceuticals Securities Litigation (TIAA et al. v. Valeant et al.)
Settlement Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2020
Indenture for $1,250,000,000 5.000% Senior Notes Due 2028 and $1,250,000,000 5.250% Senior Notes Due 2030 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2019
Indenture for $750,000,000 7.000% Senior Notes Due 2028 and $750,000,000 7.250% Senior Notes Due 2029 between Bausch Health Companies Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2019
Employment Agreement between Bausch Health Companies Inc. and Joseph F. Gordon
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2019
Valeant Pharmaceuticals International, Inc. Stock Option Grant Agreement under 2014 Omnibus Incentive Plan
Warrant Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2019
Amended and Restated Supply Agreement dated October 25, 2018 among Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals Ireland Limited, Valeant Pharmaceuticals Luxembourg s. r.l....
Supply Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2019
Amendment No. 2 to the Amended and Restated License Agreement dated October 25, 2018 among Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals Ireland Limited, Valeant...
License Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2019
Amended and Restated Asset Purchase Agreement among Synergy Pharmaceuticals Inc., Synergy Advanced Pharmaceuticals, Inc., Bausch Health Companies Inc., and Bausch Health Ireland...
Purchase Agreements
Bausch Health Companies Inc.
Pharmaceuticals
DE
2019
Bausch Health Companies Inc. Matching Restricted Stock Unit Agreement (2014 Omnibus Incentive Plan)
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2018
Form of Common Share Certificate of Bausch Health Companies Inc
Stock Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2018
Indenture Agreement for $750,000,000 8.500% Senior Notes Due 2027 between Valeant Pharmaceuticals International and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2018
Valeant Pharmaceuticals International, Inc. Performance Restricted Share Unit Grant Agreement (2014 Omnibus Incentive Plan)
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2018
Valeant Pharmaceuticals International, Inc. Nonstatutory Stock Option Grant Agreement (2014 Omnibus Incentive Plan)
Warrant Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2018
Valeant Pharmaceuticals 2014 Omnibus Incentive Plan Restricted Stock Unit Award Agreement
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2018
Valeant Pharmaceuticals International, Inc. Retention Restricted Share Unit Grant Agreement
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2018
Valeant Pharmaceuticals Director Restricted Share Unit Grant Agreement (Annual Grants)
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2018
Valeant Pharmaceuticals International, Inc. Performance Share Unit Grant Agreement (2014 Omnibus Incentive Plan)
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2018
Valeant Pharmaceuticals International, Inc. Restricted Stock Unit Award Agreement (2014 Omnibus Incentive Plan)
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2018
Valeant Pharmaceuticals International, Inc. Nonstatutory Stock Option Grant Agreement (2014 Omnibus Incentive Plan)
Stock Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2018
Employment Agreement between Valeant Pharmaceuticals International, Inc. and William D. Humphries (December 1, 2016)
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2018
Employment Agreement between Valeant Pharmaceuticals International, Inc. and Thomas J. Appio
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2018
Indenture for $1,500,000,000 9.000% Senior Notes Due 2025 between Valeant Pharmaceuticals International, Inc. and The Bank of New York Mellon
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2017
Valeant Pharmaceuticals International, Inc. Performance Restricted Share Unit Grant Agreement (2014 Omnibus Incentive Plan)
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2017
Valeant Pharmaceuticals International, Inc. Nonstatutory Stock Option Grant Agreement (2014 Omnibus Incentive Plan)
Warrant Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2017
Valeant Pharmaceuticals International, Inc. 2014 Omnibus Incentive Plan Restricted Stock Unit Award Agreement
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2017
Valeant Pharmaceuticals 2014 Omnibus Incentive Plan Make-Whole Restricted Stock Unit Award Agreement
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2017
Employment Agreement between Valeant Pharmaceuticals International, Inc. and Christina Ackermann (July 8, 2016)
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2017
Transition and Rights Affirmation Letter between Robert L. Rosiello and Valeant Pharmaceuticals International, Inc.
Transition Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2017
Separation and Consulting Agreement between Valeant Pharmaceuticals International, Inc. and Robert L. Rosiello (2017)
Separation Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2017
Separation Agreement between Valeant Pharmaceuticals International, Inc. and Robert R. Chai-Onn dated August 8, 2016
Separation Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2017
Transition and Severance Agreement between Valeant Pharmaceuticals International, Inc. and Dr. Ari S. Kellen
Transition Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2017
Separation Agreement between Valeant Pharmaceuticals International, Inc. and Ari S. Kellen (January 12, 2017)
Separation Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2017
Separation Agreement between Valeant Pharmaceuticals International, Inc. and Anne C. Whitaker (February 7, 2017)
Separation Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2017
Valeant Pharmaceuticals 2014 Omnibus Incentive Plan Matching Restricted Stock Unit Award Agreement
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2016
Joinder Agreement to Third Amended and Restated Credit and Guaranty Agreement among Valeant Pharmaceuticals, Barclays Bank PLC, and New Term Loan Lenders (April 1, 2015)
Joinder Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2015
Joinder Agreement to Third Amended and Restated Credit and Guaranty Agreement – Valeant Pharmaceuticals, Barclays, and New Term Loan Lenders (April 1, 2015)
Joinder Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2015
Indenture for Senior Notes Due 2020, 2023, and 2025 between VRX Escrow Corp. and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2015
Supplemental Indenture to Assume and Guarantee Senior Notes among Valeant Pharmaceuticals, Guarantors, and Trustee (March 27, 2015)
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2015
Underwriting Agreement for $1,450,000,000 Common Shares between Valeant Pharmaceuticals International, Inc. and Deutsche Bank Securities Inc.
Underwriting Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2015
Amendment No. 1 to Agreement and Plan of Merger among Valeant Pharmaceuticals, Sun Merger Sub, and Salix Pharmaceuticals
Merger Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2015
Valeant Pharmaceuticals International, Inc. Performance Restricted Share Unit Grant Agreement (2014 Omnibus Incentive Plan)
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2015
Valeant Pharmaceuticals International, Inc. Nonstatutory Stock Option Grant Agreement under 2014 Omnibus Incentive Plan
Equity Distribution Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2015
Valeant Pharmaceuticals 2014 Omnibus Incentive Plan Matching Restricted Stock Unit Award Agreement
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2015
Successor Agent Agreement and Amendment No. 9 to Third Amended and Restated Credit and Guaranty Agreement among Barclays Bank PLC, Goldman Sachs Lending Partners LLC, Valeant...
Credit Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2015
Joinder Agreement to Third Amended and Restated Credit and Guaranty Agreement – Valeant Pharmaceuticals, Barclays Bank PLC, and New Revolving Loan Lenders
Joinder Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2015
Joinder Agreement to Third Amended and Restated Credit and Guaranty Agreement among Valeant Pharmaceuticals, New Term Loan Lenders, and Barclays Bank PLC
Joinder Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2015
Agreement and Plan of Merger among Valeant Pharmaceuticals International, Sun Merger Sub, Inc., Valeant Pharmaceuticals International, Inc., and Salix Pharmaceuticals, Ltd....
Merger Agreements
Bausch Health Companies Inc.
Pharmaceuticals
DE
2015
Indenture for 5.50% Senior Notes Due 2023 between Valeant Pharmaceuticals International, Inc. and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2015
Indenture for 5.625% Senior Notes Due 2021 between Valeant Pharmaceuticals International, Inc. and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Amendment No. 1 to Agreement and Plan of Merger among Valeant Pharmaceuticals, Stratos Merger Corp., and Bausch & Lomb Holdings
Merger Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2013
Amendment No. 2 to Agreement and Plan of Merger among Valeant Pharmaceuticals, Stratos Merger Corp., and Bausch & Lomb Holdings
Merger Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2013
Thirteenth Supplemental Indenture to 6.75% Senior Notes Due 2021 – Valeant Pharmaceuticals, Sanitas, and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Fourteenth Supplemental Indenture to 6.875% Senior Notes Due 2018 – Valeant Pharmaceuticals, Sanitas, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Fifteenth Supplemental Indenture to 2010 Indenture among Valeant Pharmaceuticals, Sanitas, and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Indenture for VPII Escrow Corp. 6.75% Senior Notes Due 2018 and 7.50% Senior Notes Due 2021 with The Bank of New York Mellon Trust Company, N.A. as Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Valeant Pharmaceuticals International, Inc. $2 Billion Common Shares Underwriting Agreement with Goldman, Sachs & Co. and Goldman Sachs Canada Inc.
Underwriting Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Agreement and Plan of Merger among Valeant Pharmaceuticals International, Stratos Merger Corp., and Bausch & Lomb Holdings Incorporated (May 24, 2013)
Merger Agreements
Bausch Health Companies Inc.
Pharmaceuticals
DE
2013
First Supplemental Indenture to 6.375% Senior Notes Due 2020—Valeant Pharmaceuticals, Medicis, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Joinder Agreement to Third Amended and Restated Credit and Guaranty Agreement among Valeant Pharmaceuticals International, Inc., Subsidiaries, New Revolving Loan Lenders, and...
Joinder Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2012
Joinder Agreement to Third Amended and Restated Credit and Guaranty Agreement among Valeant Pharmaceuticals International, Inc., New Term Loan Lenders, and Goldman Sachs Lending...
Joinder Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2012
Agreement and Plan of Merger among Medicis Pharmaceutical Corporation, Valeant Pharmaceuticals International, Valeant Pharmaceuticals International, Inc., and Merlin Merger Sub,...
Merger Agreements
Bausch Health Companies Inc.
Pharmaceuticals
DE
2012
Joinder Agreement to Third Amended and Restated Credit and Guaranty Agreement among Valeant Pharmaceuticals International, Inc., New Term Loan Lenders, and Goldman Sachs Lending...
Joinder Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2012
Joinder Agreement to Third Amended and Restated Credit and Guaranty Agreement among Valeant Pharmaceuticals, New Term Loan Lenders, and Goldman Sachs Lending Partners LLC
Joinder Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2012
Valeant Pharmaceuticals 2011 Omnibus Incentive Plan Matching Restricted Stock Unit Award Agreement
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2012
Valeant Pharmaceuticals International, Inc. Performance Restricted Share Unit Grant Agreement (2011 Omnibus Incentive Plan)
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2012
Valeant Pharmaceuticals International, Inc. Directors Share Unit Plan (Effective May 16, 2011)
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2011
License Agreement between Meda Pharma SARL and Valeant International (Barbados) SRL for Xerese and Elidel Rights
License Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2011
Stock Purchase Agreement between Biovail International S.à.r.l. and the Stockholders of PharmaSwiss SA (January 31, 2011)
Stock Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2011
Trademark and Domain Name License Agreement between GlaxoSmithKline LLC and Biovail Laboratories International SRL
License Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2011
Valeant Pharmaceuticals International, Inc. Nonstatutory Stock Option Grant under 2007 Equity Compensation Plan
Stock Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2011
Valeant Pharmaceuticals International, Inc. Unit Grant Agreement under 2007 Equity Compensation Plan
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2011
Valeant Pharmaceuticals International, Inc. Performance Restricted Share Unit Grant Notice (2007 Equity Compensation Plan)
Bonus & Incentive Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2011
Consulting Agreement between Valeant Pharmaceuticals International, Inc. and Margaret Mulligan
Consulting Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2010
Indenture Agreement for 3.0% and 4.0% Convertible Subordinated Notes between Valeant Pharmaceuticals International, Ribapharm Inc., and The Bank of New York (Trustee)
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2010
Credit and Guaranty Agreement among Valeant Pharmaceuticals International, Biovail Corporation, and Lenders (2010)
Credit Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2010
Counterpart Agreement to Credit and Guaranty Agreement – Valeant Pharmaceuticals International, Inc. and Goldman Sachs Lending Partners LLC
Guaranty Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2010
Agreement and Plan of Merger among Biovail Americas Corp., Prestwick Holdings, Inc., Prestwick Pharmaceuticals, Inc., and Stockholder Representatives (2008)
Merger Agreements
Bausch Health Companies Inc.
Pharmaceuticals
DE
2010
Asset Purchase Agreement between Biovail Laboratories International SRL and SmithKline Beecham Corporation (GlaxoSmithKline)
Purchase Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2010
Amendment No. 1 to Asset Purchase Agreement between Cambridge Laboratories (Ireland) Limited and Biovail Laboratories International (Barbados) SRL, dated June 19, 2009
Purchase Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2010
Employment Agreement between Valeant Pharmaceuticals International, Inc. and Paul Herendeen
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2016
Separation Agreement between Valeant Pharmaceuticals International, Inc. and J. Michael Pearson
Separation Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2016
Valeant Pharmaceuticals Executive Retention Letter Agreement (Form)
Retention Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2016
Valeant Pharmaceuticals and Brian Stolz Employment Letter Agreement (July 1, 2015)
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2016
Employment Agreement between Anne Whitaker and Valeant Pharmaceuticals International, Inc. (April 25, 2015)
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2016
Valeant Pharmaceuticals North America LLC Employment Offer Letter to Deborah Jorn (July 23, 2013)
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2016
Employment Agreement between Valeant Pharmaceuticals International, Inc. and Joseph C. Papa (CEO)
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2016
Interim Chief Executive Officer Employment Letter Agreement between Valeant Pharmaceuticals International, Inc. and Howard B. Schiller
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2016
Employment Agreement between Valeant Pharmaceuticals International, Inc. and Robert Rosiello (June 10, 2015)
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2015
Separation and Consulting Agreement between Valeant Pharmaceuticals International, Inc. and Howard B. Schiller
Separation Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2015
Employment Agreement between Valeant Pharmaceuticals International, Inc. and Dr. Ari Kellen (Executive Vice President)
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2015
Employment Agreement between PharmaSwiss AG and Pavel Mirovsky dated April 2, 2012
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2015
Commitment Letter for Acquisition Financing – Valeant Pharmaceuticals International, Inc. and Lenders (Project Sun)
Bausch Health Companies Inc.
Pharmaceuticals
NY
2015
Second Amended and Restated Employment Agreement between Valeant Pharmaceuticals International, Inc. and J. Michael Pearson
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
DE
2015
Separation Agreement between Valeant Pharmaceuticals International, Inc. and Daniel Wechsler (February 28, 2014)
Separation Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2014
Valeant Pharmaceuticals Executive Employment Agreement with Robert Chai-Onn (2014)
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2014
Valeant Pharmaceuticals Executive Employment Offer Letter with Laizer Kornwasser (2013)
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2014
Second Supplemental Indenture to VPII Escrow July 2013 Indenture among Valeant Pharmaceuticals, Obagi Medical Products, OMP, and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Second Supplemental Indenture to 6.375% Senior Notes Due 2020—Valeant, Obagi, OMP, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Third Supplemental Indenture among Valeant Pharmaceuticals, Obagi Medical Products, OMP, and The Bank of New York Mellon Trust Company (July 26, 2013)
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Sixth Supplemental Indenture to 2011 Indenture among Valeant Pharmaceuticals, Obagi Medical Products, OMP, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Sixth Supplemental Indenture to 6.75% Senior Notes Due 2021—Valeant Pharmaceuticals, Obagi Medical Products, OMP, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Seventh Supplemental Indenture to 6.875% Senior Notes Due 2018—Valeant, Obagi, OMP, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Eighth Supplemental Indenture to 2010 Indenture among Valeant Pharmaceuticals, Obagi Medical Products, OMP, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Third Supplemental Indenture to VPII Escrow July 2013 Indenture among Valeant Pharmaceuticals, Bausch & Lomb Holdings, Bausch & Lomb Incorporated, and The Bank of New York Mellon...
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Fourth Supplemental Indenture to 6.375% Senior Notes Due 2020—Valeant Pharmaceuticals, Bausch & Lomb Holdings, Bausch & Lomb Inc., and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Seventh Supplemental Indenture to 2011 Indenture among Valeant Pharmaceuticals, Bausch & Lomb Holdings, Bausch & Lomb Inc., and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Seventh Supplemental Indenture to 6.75% Senior Notes Due 2021 among Valeant Pharmaceuticals, Bausch & Lomb Holdings, Bausch & Lomb Incorporated, and The Bank of New York Mellon...
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Eighth Supplemental Indenture to 6.875% Senior Notes Due 2018—Valeant Pharmaceuticals, Bausch & Lomb Holdings, Bausch & Lomb Inc., and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Ninth Supplemental Indenture to 2010 Indenture among Valeant Pharmaceuticals, Bausch & Lomb Holdings, Bausch & Lomb Incorporated, and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Fourth Supplemental Indenture to VPII Escrow July 2013 Indenture among Valeant Pharmaceuticals Entities and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Fifth Supplemental Indenture to 6.375% Senior Notes Due 2020 – Valeant Pharmaceuticals and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Eighth Supplemental Indenture to March 2011 Indenture among Valeant Pharmaceuticals Entities and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Eighth Supplemental Indenture to 6.75% Senior Notes Due 2021—Valeant Pharmaceuticals and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Ninth Supplemental Indenture to 6.875% Senior Notes Due 2018—Valeant Pharmaceuticals and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Tenth Supplemental Indenture to Valeant Pharmaceuticals International Indenture (2010)
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Fifth Supplemental Indenture to VPII Escrow July 2013 Indenture among Valeant Pharmaceuticals, UCYCLYD Pharma, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Sixth Supplemental Indenture to 6.375% Senior Notes Due 2020 – Valeant Pharmaceuticals, UCYCLYD Pharma, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Ninth Supplemental Indenture to 2011 Indenture among Valeant Pharmaceuticals, UCYCLYD Pharma, and BNY Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Ninth Supplemental Indenture to 6.75% Senior Notes Due 2021—Valeant Pharmaceuticals, UCYCLYD Pharma, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Tenth Supplemental Indenture to 6.875% Senior Notes Due 2018 – Valeant Pharmaceuticals, UCYCLYD Pharma, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Eleventh Supplemental Indenture to 2010 Indenture among Valeant Pharmaceuticals, UCYCLYD Pharma, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Sixth Supplemental Indenture to VPII Escrow July 2013 Indenture by Valeant Pharmaceuticals, Jelfa, Valeant Europe B.V., and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Seventh Supplemental Indenture to 6.375% Senior Notes Due 2020 – Valeant Pharmaceuticals, Jelfa, Valeant Europe B.V., and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Tenth Supplemental Indenture to 2011 Indenture for Valeant Pharmaceuticals International Senior Notes
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Tenth Supplemental Indenture to 6.75% Senior Notes Due 2021—Valeant Pharmaceuticals, Jelfa, Valeant Europe B.V., and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Eleventh Supplemental Indenture to 6.875% Senior Notes Due 2018—Valeant Pharmaceuticals, Jelfa, Valeant Europe B.V., and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Twelfth Supplemental Indenture to 2010 Indenture among Valeant Pharmaceuticals International, Jelfa, VEBV, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Seventh Supplemental Indenture to VPII Escrow July 2013 Indenture among Valeant Entities and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Eighth Supplemental Indenture to 6.375% Senior Notes Due 2020—Valeant Pharmaceuticals, VLLC, VP, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Eleventh Supplemental Indenture to 2011 Indenture among Valeant Entities and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Eleventh Supplemental Indenture to 6.75% Senior Notes Due 2021—Valeant Pharmaceuticals, VLLC, VP, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Twelfth Supplemental Indenture to 6.875% Senior Notes Due 2018—Valeant Pharmaceuticals, VLLC, VP, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Thirteenth Supplemental Indenture to 2010 Indenture among Valeant Pharmaceuticals International, VLLC, VP, and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Eighth Supplemental Indenture to VPII Escrow July 2013 Indenture among Valeant Pharmaceuticals, Labenne Participações, Probiótica Laboratórios, and The Bank of New York Mellon...
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Ninth Supplemental Indenture to 6.375% Senior Notes Due 2020 – Valeant Pharmaceuticals, Labenne Participações, Probiótica, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Twelfth Supplemental Indenture to 2011 Indenture among Valeant Pharmaceuticals International, Labenne Participações Ltda., Probiótica Laboratórios Ltda., and The Bank of New...
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Twelfth Supplemental Indenture to 6.75% Senior Notes Due 2021—Valeant Pharmaceuticals, Labenne Participações, Probiótica, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Thirteenth Supplemental Indenture to 6.875% Senior Notes Due 2018—Valeant Pharmaceuticals, Labenne Participações, Probiótica, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Fourteenth Supplemental Indenture to 2010 Indenture among Valeant Pharmaceuticals International, Labenne Participações Ltda., Probiótica Laboratórios Ltda., and The Bank of...
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Ninth Supplemental Indenture to July 2013 Indenture—Valeant Pharmaceuticals, Sanitas, and BNY Mellon Trust
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Tenth Supplemental Indenture to 6.375% Senior Notes Due 2020 – Valeant Pharmaceuticals, Sanitas, and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Thirteenth Supplemental Indenture to 2011 Indenture among Valeant Pharmaceuticals, Sanitas, and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Supplemental Indenture and Assumption Agreement among Valeant Pharmaceuticals, Guarantors, and Trustee (July 12, 2013)
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Valeant Pharmaceuticals and Goldman Sachs Commitment Letter for Bridge Loan Financing (Project Stratos)
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Separation Agreement between Valeant Pharmaceuticals International, Inc. and Jason Hanson (May 8, 2013)
Separation Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2013
Seventh Supplemental Indenture to 2010 Indenture among Medicis, Valeant Pharmaceuticals International, and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Sixth Supplemental Indenture to 6.875% Senior Notes Due 2018 – Medicis, Valeant Pharmaceuticals International, and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Fifth Supplemental Indenture to 6.75% Senior Notes Due 2021 among Medicis Pharmaceutical Corporation, Valeant Pharmaceuticals International, and The Bank of New York Mellon Trust...
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Fifth Supplemental Indenture to 2011 Indenture among Medicis Pharmaceutical, Valeant Pharmaceuticals International, and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Second Supplemental Indenture to 6.375% Senior Notes Due 2020 among Medicis Pharmaceutical, Valeant Pharmaceuticals, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2013
Asset Purchase Agreement between Medicis Pharmaceutical Corporation and Graceway Pharmaceuticals, LLC (November 18, 2011)
Purchase Agreements
Bausch Health Companies Inc.
Pharmaceuticals
IL
2013
Valeant Pharmaceuticals Executive Employment Offer Letter to Ryan Weldon (Medicis Merger Contingent)
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2013
Valeant Pharmaceuticals Executive Employment Offer Letter to Jason – December 2012
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2013
Amendment No. 1 to Third Amended and Restated Credit and Guaranty Agreement among Valeant Pharmaceuticals International, Inc. and Lenders
Modification Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2012
Amendment No. 2 to Third Amended and Restated Credit and Guaranty Agreement by and among Valeant Pharmaceuticals International, Inc., Goldman Sachs Lending Partners LLC, and...
Credit Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2012
Amended and Restated Commitment Letter for Bridge Loan Facility – Valeant Pharmaceuticals and Lender Group
Bausch Health Companies Inc.
Pharmaceuticals
NY
2012
Separation Agreement between Valeant Pharmaceuticals International, Inc. and Rajiv De Silva (2012)
Separation Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2012
Indenture for VPI Escrow Corp. 6.375% Senior Notes Due 2020 with The Bank of New York Mellon Trust Company, N.A. as Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2012
Supplemental Indenture to Escrow Corp Indenture among Valeant Pharmaceuticals, Subsidiary Guarantors, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2012
Indenture for Valeant Pharmaceuticals International 6.375% Senior Notes Due 2020 with The Bank of New York Mellon Trust Company, N.A. as Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2012
Commitment Letter for Bridge Loan Facility – Valeant Pharmaceuticals International, Inc. and JPMorgan Chase Bank, N.A.
Bausch Health Companies Inc.
Pharmaceuticals
NY
2012
First Supplemental Indenture to 5.375% Senior Convertible Notes Due 2014 between Valeant Pharmaceuticals International, Inc., The Bank of New York Mellon, and BNY Trust Company of...
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2012
Fifth Supplemental Indenture to 2010 Indenture among Valeant Pharmaceuticals Entities and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2012
Fourth Supplemental Indenture to 6.875% Senior Notes Due 2018—Valeant Pharmaceuticals and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2012
Third Supplemental Indenture to 6.75% Senior Notes Due 2021—Valeant Pharmaceuticals and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2012
Third Supplemental Indenture to 2011 Indenture—Valeant Pharmaceuticals and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2012
Sixth Supplemental Indenture to Valeant Pharmaceuticals Senior Notes Guarantee by Orapharma, Inc. and Orapharma Topco Holdings, Inc.
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2012
Fifth Supplemental Indenture to 6.875% Senior Notes Due 2018—Valeant Pharmaceuticals, Orapharma, and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2012
Fourth Supplemental Indenture to 6.75% Senior Notes Due 2021—Valeant Pharmaceuticals, Orapharma, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2012
Fourth Supplemental Indenture to Valeant Pharmaceuticals Senior Notes Guarantee by Orapharma, Inc. and Orapharma Topco Holdings, Inc.
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2012
Second Supplemental Indenture to 2010 Valeant Senior Notes Indenture—Valeant Pharmaceuticals, New Guarantors, and Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2012
First Supplemental Indenture to 6.875% Senior Notes Due 2018—Valeant Pharmaceuticals, Valeant Canada Entities, and The Bank of New York Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2012
Valeant Pharmaceuticals International, Inc. Nonstatutory Stock Option Grant Agreement under 2011 Omnibus Incentive Plan
Warrant Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2012
Employment Agreement between Valeant Pharmaceuticals International, Inc. and Howard Schiller (CFO Appointment)
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2012
Valeant Pharmaceuticals International, Inc. Executive Employment and Equity Award Agreement with Rich (2010)
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2012
Amendment No. 2 to Amended and Restated Credit and Guaranty Agreement by and among Valeant Pharmaceuticals International and Goldman Sachs Lending Partners LLC
Credit Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2012
Second Amended and Restated Credit and Guaranty Agreement among Valeant Pharmaceuticals International, Inc., Subsidiaries, and Lenders
Credit Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2011
Amendment No. 3 to Amended and Restated Credit and Guaranty Agreement among Valeant Pharmaceuticals International, Valeant Pharmaceuticals International, Inc., Goldman Sachs...
Credit Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2011
First Supplemental Indenture to 2011 Indenture among Valeant Pharmaceuticals International, Biovail International S.à r.l., PharmaSwiss SA, and The Bank of New York Mellon Trust...
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2011
First Supplemental Indenture to 6.75% Senior Notes Due 2021—Valeant Pharmaceuticals, Biovail International, PharmaSwiss, and BNY Mellon Trust Company
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2011
Second Supplemental Indenture among Valeant Pharmaceuticals International, Biovail International S.à r.l., PharmaSwiss SA, and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2011
Third Supplemental Indenture Among Valeant Pharmaceuticals International, Biovail International S.à r.l., PharmaSwiss SA, and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2011
Amended and Restated Credit and Guaranty Agreement among Valeant Pharmaceuticals International, Inc., Subsidiaries, and Goldman Sachs Lending Partners LLC
Credit Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2011
Amendment No. 1 to Credit and Guaranty Agreement among Valeant Pharmaceuticals International, Inc., Subsidiaries, and Goldman Sachs Lending Partners LLC
Credit Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2011
Amendment No. 1 to Amended and Restated Credit and Guaranty Agreement by and among Valeant Pharmaceuticals International, Goldman Sachs Lending Partners LLC, and Requisite Lenders
Credit Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2011
Asset Purchase Agreement among Sanofi, Valeant International (Barbados) SRL, and Valeant Pharmaceuticals International, Inc. dated July 8, 2011
Purchase Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2011
Asset Purchase Agreement among Janssen Pharmaceuticals, Inc. and Valeant Entities (July 15, 2011)
Purchase Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2011
Separation Agreement between Valeant Pharmaceuticals International, Inc. and Mark Durham (July 7, 2011)
Separation Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2011
Employment Offer Letter Agreement between Valeant Pharmaceuticals International, Inc. and Brian Stolz (June 27, 2011)
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2011
Credit and Guaranty Agreement among Valeant Pharmaceuticals International, Inc., Subsidiaries, and Goldman Sachs Lending Partners LLC for $200 Million Revolving Credit Facility
Credit Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2011
Purchase Agreement between ValueAct Capital Master Fund, L.P. and 0909657 B.C. Ltd. for Valeant Pharmaceuticals Shares
Purchase Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2011
Amended and Restated Employment Agreement between Valeant Pharmaceuticals International, Inc. and J. Michael Pearson
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NJ
2011
Indenture for Valeant Pharmaceuticals International 6.500% Senior Notes Due 2016 and 7.250% Senior Notes Due 2022 with The Bank of New York Mellon Trust Company, N.A., as Trustee
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
DE
2011
Asset Purchase Agreement between Biovail Laboratories International SRL and GlaxoSmithKline LLC (February 2, 2011)
Purchase Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2011
Purchase Agreement between ValueAct Capital Master Fund, L.P. and Valeant Pharmaceuticals International, Inc. dated February 24, 2011
Purchase Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2011
Amendment No. 1 to Credit and Guaranty Agreement among Valeant Pharmaceuticals International, Inc., Subsidiaries, Lenders, and Goldman Sachs Lending Partners LLC
Modification Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2011
Indenture for 6.750% Senior Notes Due 2021 between Valeant Pharmaceuticals International and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
DE
2011
Separation Agreement between Valeant Pharmaceuticals International, Inc. and Margaret Mulligan
Separation Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2010
Separation Agreement between Valeant Pharmaceuticals International, Inc. and William M. Wells
Separation Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2010
Separation Agreement between Valeant Pharmaceuticals International, Inc., Biovail Laboratories International SRL, and William M. Wells
Separation Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2010
Indenture for 6.875% Senior Notes Due 2018 between Valeant Pharmaceuticals International and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
DE
2010
Employment Agreement between Valeant Pharmaceuticals International, Inc. and Rajiv De Silva (President and COO)
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2010
Employment Agreement between Valeant Pharmaceuticals International, Inc. and Margaret Mulligan (CFO)
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2010
Valeant Pharmaceuticals Executive Employment Agreement with Robert Chai-Onn (2010)
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2010
Valeant Pharmaceuticals International, Inc. Employment Offer Letter to Mark Durham (Senior Vice President, Human Resources)
Employment Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2010
Indenture Agreement for Valeant Pharmaceuticals International 6.75% Senior Notes Due 2017 and 7.00% Senior Notes Due 2020 with The Bank of New York Mellon Trust Company, N.A. as...
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2010
First Supplemental Indenture among Valeant Pharmaceuticals International, Biovail Corporation, and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
Bausch Health Companies Inc.
Pharmaceuticals
NY
2010
Asset Purchase Agreement between Cambridge Laboratories (Ireland) Limited and Biovail Laboratories International (Barbados) SRL dated May 16, 2009
Purchase Agreements
Bausch Health Companies Inc.
Pharmaceuticals
2010